Any substantial reduction in gun violence will require a comprehensive approach to the issue, write the authors of a report on the reality of firearm violence in the Houston area.
Ned Levine, Cary Cain, Lisa Pompeii, Abiodun Oluyomi, Bindi Naik-MathuriaMay 30, 2023
This report finds that America's largest companies could be increasing their profits by identifying opportunities to reign in the costs of health insurance coverage — while still maintaining or improving the quality of benefits for their employees.
A regulation from the Centers for Medicare and Medicaid Services (CMS) required that, starting January 1, 2021, all U.S. hospitals publicly display the cash price as well as the minimum and maximum negotiated charge for 300 “shoppable services.”
Vivian Ho, Alan Beltran Lara, David Ruiz, Peter Cram, M.D., Marah ShortMay 12, 2022
This report finds that less than half of Texas hospitals are complying with federal price transparency regulations, despite a measure passed by the state Legislature intended to increase the financial penalty for noncompliance.
Vivian Ho, Marah Short, Vivian Ye, Patrick SolcherMarch 21, 2022
In this report, the authors outline the U.S. federal budget process for scientific R&D, discuss trends in federal R&D funding and provide an outlook for federal scientific R&D funding during the Biden administration.
By Paul Lagunes, Baker Institute for Public Policy; Xiaoxuan Yang, Columbia University; and Andrés Castro, Columbia University.
Corruption is a persistent problem throughout Latin America. Higher rates of perceived corruption are associated with lower levels of economic welfare and direct foreign investment, write the authors.
Paul Lagunes, Xiaoxuan Yang, Andrés CastroJuly 8, 2019
This paper summarizes the presentations and discussions at May 14, 2015, workshop on water-energy interdependence and related issues. The Baker Institute Center for Energy Studies (CES) and the Texas A&M University Nexus Research Group convened the event.
This report describes the problems associated with unproven stem cell treatments, focusing on those without FDA approval undertaken by NFL players in the past five years.